Accelr8 Technology Corporation
Overview
An in-vitro diagnostics company that provides solutions for the rapid diagnosis of serious infections to address the global challenges of antibiotic resistance and sepsis. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. In May 2025, the company initiated a voluntary Chapter 11 restructuring proceeding.
Portfolio Companies
3
Website
acceleratediagnostics.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BlocPower | Feb 2021 | Series A | Lead |
| Andes Ag, Inc. | Mar 2023 | Series A Extension | Co-investor |
| Elo Life Systems | Jan 2024 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Accelr8 Technology Corporation based?
Accelr8 Technology Corporation is headquartered in Tucson, Arizona, United States.
When was Accelr8 Technology Corporation founded?
Founding year information for Accelr8 Technology Corporation is not publicly available.
How many portfolio companies does Accelr8 Technology Corporation have?
Accelr8 Technology Corporation has 3 portfolio companies in Caplight's dataset.
What are some companies in Accelr8 Technology Corporation's portfolio?
Portfolio companies visible on Caplight include BlocPower, Andes Ag, Inc., Elo Life Systems.
What was Accelr8 Technology Corporation's most recent investment shown here?
Accelr8 Technology Corporation's most recent investment in this portfolio sample was in Elo Life Systems in 2024.
What sectors does Accelr8 Technology Corporation focus on?
Accelr8 Technology Corporation focuses on Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Real Estate & PropTech.
What company stages does Accelr8 Technology Corporation focus on?
Accelr8 Technology Corporation typically invests at the Early stage.